DUBLIN, May 11, 2018 /PRNewswire/ -- The "Market Spotlight: Opioid-Induced Constipation" report has been added to ResearchAndMarkets.com's offering.
This Market Spotlight report covers the Opioid-Induced Constipation market, comprising key pipeline and marketed drugs, clinical trials, upcoming and regulatory events, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals.
Key Takeaways
- The approved drugs in the OIC space predominantly target opioid receptors, with the exception of Amitiza, a type-2 chloride channel activator. All of the marketed drugs are administered via the oral route, with one product also available in subcutaneous formulation.
- The majority of industry-sponsored drugs in active clinical development for OIC are in Phase II, with only one drug in Phase III. Therapies in mid-to-late-stage development for OIC focus on targets such as opioid receptors and guanylyl cyclase c receptor. All of the pipeline drugs are administered via the oral route.
- A Committee for Medicinal Products for Human Use (CHMP) opinion for Symproic is the only high-impact upcoming event in the OIC space.
- There was only one licensing agreement involving OIC drugs during 2013-17.
Key Topics Covered:
KEY TAKEAWAYS
DISEASE BACKGROUND
TREATMENT
Management of OIC with laxatives
Management of OIC with opioid antagonists
Management of OIC with Amitiza, a secretagogue chloride channel activator
EPIDEMIOLOGY
Recent Prevalence Studies
Challenges
MARKETED DRUGS
PIPELINE DRUGS
KEY UPCOMING EVENTS
KEY REGULATORY EVENTS
Purdue Highlights Convenience Of New Opioid-Induced Constipation Drug Symproic
Valeant's Oral Relistor Poised To Face-Off Against AstraZeneca's Movantik
LICENSING AND ASSET ACQUISITION DEALS
PARENT PATENTS
REVENUE OPPORTUNITY
BIBLIOGRAPHY
Prescription Information
APPENDIX
For more information about this report visit https://www.researchandmarkets.com/research/2fwbfb/global?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets